For nearly four decades, Biogen has been a leader in groundbreaking scientific innovations that have made a difference in the lives of patients. We are committed to bringing novel therapies to market, focusing on hard-to-treat disease areas with significant unmet medical need.

Partnerships are absolutely essential. We partner with people who we believe are among the best in the world at what they do.

— George A. Scangos, Biogen CEO

While our own research teams are making significant scientific advancements in-house, we recognize that no one has a monopoly on innovation. That creates a critical need for collaboration and finding the right partners to advance new ideas, modalities and thinking to create new therapies for patients. We highly value the insights and expertise of other companies and academic laboratories and believe that they are necessary to complement our internal skills and knowledge. At our core, we know that by bringing together many different disciplines to tackle complex challenges we can advance medicine more rapidly and effectively.

Successful collaborations are built on a foundation of mutual respect, aligned interests and a goal of improving the lives of people with serious diseases. We work to structure collaborations so they benefit all parties — and we look to work with organizations at all stages in the development process.